Should Coronary Revascularization Precede Transcatheter Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials
This meta-analysis of three randomized controlled trials involving 1,156 patients indicates that routine percutaneous coronary intervention (PCI) prior to transcatheter aortic valve replacement (TAVR) does not reduce mortality but significantly lowers the need for revascularization while nearly doubling the risk of bleeding, thereby supporting a selective rather than routine approach to revascularization.